In the vast majority of cases of Parkinson’s disease, or “shaking palsy,” physicians cannot be sure what originally caused the nerve damage that results in the patient’s tremor, muscle rigidity, ...

The U.S. Food and Drug Administration has given approval for the drug Stalevo-a cocktail of levodopa (L-dopa), carbidopa, and entacapone-to be marketed in the United States for the treatment of ...

PD affects an estimated 1 million people in the United States, with approximately 60,000 people newly diagnosed each year. 1 The prevalence increases with age, and because of the growing aging ...

Philadelphia (April 1, 2022) – Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson’s disease. Preclinical ...

A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD). Led by 2014 BBRF ...